In the news
‘The price is bewildering’: The cost of Biogen’s Alzheimer’s drug may lead payers to erect roadblocks
June 7, 2021STAT News
Related news
In the news
May 5, 2022
Prime Therapeutics buying Magellan Health’s pharma business for $1.35 billion
Minneapolis/St. Paul Business Journal
In the news
May 5, 2022
Prime Therapeutics paying $1.35 billion for Magellan Health’s pharmacy business
Star Tribune